SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-20-007556
Filing Date
2020-04-13
Accepted
2020-04-13 11:50:51
Documents
5
Period of Report
2020-05-15
Effectiveness Date
2020-04-13

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A atos20200131_def14a.htm DEF 14A 473272
2 a01.jpg GRAPHIC 235497
3 a02.jpg GRAPHIC 261245
4 logo.jpg GRAPHIC 11185
5 sig.jpg GRAPHIC 6165
  Complete submission text file 0001437749-20-007556.txt   1177143
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Filer) CIK: 0001488039 (see all company filings)

IRS No.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35610 | Film No.: 20788172
SIC: 2834 Pharmaceutical Preparations